Our ERS Publications podcasts feature: a monthly podcast from the European Respiratory Journal, which summarises the research findings of a number of papers published in each issue; podcasts from our book series, the ERS Monograph, with each relating to current book's topic of focus.
ERJ Podcast September 2026: The airway microbiome and targeted therapy in bronchiectasis
As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews editorial board member Christina Thornton and associate editor Marcus Mall about their Back to Basics review article on bridging the airway microbiome and targeted therapy in bronchiectasis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.00239-2026).
Cite this podcast as: ERJ Podcast September 2026: The airway microbiome and targeted therapy in bronchiectasis. Eur Respir J 2026; 68: 26E6803 [https://doi.org/10.1183/13993003.E6803-2026].
28 Aug 2026
ERJ Podcast August 2026: Fentanyl or morphine for persistent dyspnoea in COPD
As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Marlies van Dijk (University of Groningen, Groningen, The Netherlands) about her multicentre randomised crossover trial of fentanyl and morphine for persistent dyspnoea in COPD, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01431-2025).
Cite this podcast as: ERJ Podcast August 2026: Fentanyl or morphine for persistent dyspnoea in COPD. Eur Respir J 2026; 68: 26E6802 [https://doi.org/10.1183/13993003.E6802-2026].
12 Aug 2026
ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis
As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marlies Wijsenbeek about data from the whole follow-up period of the FIBRONEER-ILD trial of nerandomilast in progressive pulmonary fibrosis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01272-2025).
English and Japanese versions of the patient podcast to accompany the article are available from: https://publications.ersnet.org/content/erj/68/1/2501899#edit-group-supplementary-material
Cite this podcast as: ERJ Podcast July 2026: Nerandomilast in progressive pulmonary fibrosis. Eur Respir J 2026; 68: 26E6801 [https://doi.org/10.1183/13993003.E6801-2026].
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
4.0 / 5
5 ratings
Spotify
5.0 / 5
5 ratings
Podcast Authority Score: 37 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
62
Social presence
0
YouTube
0
Engagement
31
Contact ERS Publications Podcasts
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
